Top

BY Lany Kimmons

In the past, patients with a particular cancer type all received the same treatment, but research has shown that tumors have unique features, even within the same cancer type. Now, physicians are increasingly using cancer biomarkers to gain more information about a patient’s tumor to predict the treatment that is most likely to work against their unique cancer.

“Biomarker testing has revolutionized cancer treatment for many tumor...

BY Shanley Chien

Since the discovery of KRAS gene mutations in 1983, researchers have worked to develop new therapies that target this protein when treating...

BY Lori Baker

It takes a team to make discoveries. But MD Anderson has taken this concept well beyond the traditional partnership between students...

BY Devon Carter

B-cell lymphoma isn’t one disease. There are about 63 subtypes, with diffuse large B-cell lymphoma (DLBCL) being the most common. A chemotherapy regimen called R-CHOP has been the standard treatment approach since 2002, when the antibody therapy rituximab was added to the chemotherapy regimen CHOP.

Almost 60% of patients find success with R-CHOP. But what about the remaining 40% of B-cell lymphoma patients?

“The success...

Illustration of B-cell lymphoma cell

BY Devon Carter

First emerging almost three decades ago, monoclonal antibodies are changing the way doctors treat cancer and other illnesses, including COVID...

BY Devon Carter

Clinical trials are how progress is made in medicine. “They’re really essential to drive our ability to deliver better cancer care,” says...

BY Clayton Boldt, Ph.D.

In the last decade, immunotherapy has become a viable treatment option for many cancer patients. Unlike radiation and chemotherapy, immunotherapy...

BY Clayton Boldt, Ph.D.

Does social distancing effectively prevent the spread of SARS-CoV-2, the virus that causes COVID-19?

New research from MD Anderson...

BY Clayton Boldt, Ph.D.

After completing a course of treatment, there are few words that sound better to a patient than “complete remission.” It’s an indication that...

BY Devon Carter

Natural killer cells – or NK cells – are part of our immune system. They patrol our bodies for abnormal cells like cancer and destroy them...